Luye Pharma Group (HK:2186) has released an update.
Luye Pharma Group Ltd. has scheduled a board meeting for August 28, 2024, to review and approve the interim financial results for the first half of the year and to discuss the potential distribution of an interim dividend. The announcement underscores the company’s commitment to transparency and shareholder value.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
